Skip to main content

Table 2 Management and outcome data of reported cases of DSF after gastrectomy for malignant disease

From: Management of duodenal stump fistula after gastrectomy for malignant disease: a systematic review of the literature

Author/Year Management Outcomes Hospital stay, Healing time, DSF-related
median days (range) median days (range) mortality rate (%)
Conservative Endoscopic Percutaneous Surgical
Transhepatic biliary diversion Abscess/Abdominal drainage Duodenostomy
Garden et al./1988 [9] 5 0 0 5 0 0 Conservative: 5/5 solved NA 35 (17–71)a 0% (0/5)
Endoscopic: −/−
Percutaneous: 5/5 solved
Surgical: −/−
Bloch et al./1989 [10] 0 1 0 0 0 0 Conservative: −/− NA 35 0% (0/1)
Endoscopic: 1/1 solved
Percutaneous: −/−
Surgical: −/−
Kyzer et al./1997 [11] 1 0 0 0 0 1 Conservative: 1/1 solved NA NA 50% (1/2)
Endoscopic: −/−
Percutaneous: −/−
Surgical: 0/1 solved
Wong et al./2000 [12] 0 1 0 0 0 0 Conservative: −/− NA 2 0% (0/1)
Endoscopic: 1/1 solved
Percutaneous: −/−
Surgical: −/−
Oh et al./2009 [13] 0 0 0 0 0 5 Conservative: −/− NA 18 (10–28)a 0% (0/5)
Endoscopic: −/−
Percutaneous: −/−
Surgical: 5/5 solved
Lee et al./2009 [14] 0 1 0 0 0 0 Conservative: −/− 34 17 0% (0/1)
Endoscopic: 1/1 solved
Percutaneous: −/−
Surgical: −/−
Cozzaglio et al./2010 [5] 51 0 4 15 2 27 Conservative: NA/NA 21 (7–65) without complications; 31 (1–1035) with complications 19 (1–1035) 16.2% (11/68)
Endoscopic: −/−
Percutaneous: NA/NA
Surgical: NA/NA
Hur et al./2010 [15] 0 0 0 0 4 1 Conservative: −/− 48 (30–158) 21 (12–44) 0% (0/4)
Endoscopic: −/−
Percutaneous: 3/4 solved
Surgical: 1/1 solved
Cozzaglio et al./2011 [16] 6 0 6 5 0 0 Conservative: 0/6 solved 63 (40–167) 63 (40–621) 50% (3/6)
Endoscopic: −/−
Percutaneous: 0/5 PAD; 3/6 PTBD-OD solved
Surgical: −/−
Curcio et al./2012 [17] 0 1 1 1 0 0 Conservative: −/− NA 60 0% (0/1)
Endoscopic: 1/1 solved
Percutaneous: 0/2 solved
Surgical: −/−
Oh et al./2013 [18] 0 0 0 0 10 0 Conservative: −/− 32 (18–57) 51 (23–89) 0% (0/10)
Endoscopic: −/−
Percutaneous: 10/10 solved
Surgical: −/−
Blouhos et al./2013 [19] 0 0 0 0 0 1 Conservative: −/− 36 45 0% (0/1)
Endoscopic: −/−
Percutaneous: −/−
Surgical: 1/1 solved
Vasiliadis et al./2014 [20] 0 0 0 0 0 1 Conservative: −/− 17 15 0% (0/1)
Endoscopic: −/−
Percutaneous: −/−
Surgical: 1/1 solved
Kim et al./2014 [21] 3 0 0 0 0 10 Conservative: 3/3 solved 26 (12–140) 11.7 (8–18) conservative group, 57.3 (14–134) surgical groupa 15.4% (2/13)
Endoscopic: −/−
Percutaneous: −/−
Surgical: 8/10 solved
Orsenigo et al./2014 [3] 11 0 3 5 0 13 Conservative: 11/11 solved NA 31.2 ± 19.7 (conservative, PTBD and drainage); 45.2 ± 57.4 (surgical)a 9.4% (3/32)
Endoscopic: −/−
Percutaneous: 8/8 solved
Surgical: 10/13 solved
Cornejo et al./2016 [22] 5 0 0 0 0 8 Conservative: 5/5 solved 39.5 (26–65) conservative; 34.3 (13–84) surgicala NA 46.2% (6/13)
Endoscopic: −/−
Percutaneous: −/−
Surgical: 2/8 solved
Cozzaglio et al./2016 [4] 0 0 0 0 0 75 Conservative: −/− 39 (22–68) solved; 32 (18–41) overall 28.5 (18–60) 1 surgical operation; 63 (50–82) > 1 surgical operation 28% (21/75)
Endoscopic: −/−
Percutaneous: −/−
Surgical: 54/75 solved
Ali et al./2016 [7] 5 0 0 11 3 5 Conservative: 5/5 solved 22 (11–96) NA 0% (0/24)
Endoscopic: −/−
Percutaneous: 14/14 solved
Surgical: 5/5 solved
Paik et al./2016 [6] 6 0 6 1 0 3 Conservative: 6/6 solved 27.5 (15–54) solved group NA 12,5% (2/16)
Endoscopic: −/−
Percutaneous: 6/7 solved
Surgical: 2/3 solved
Ramos et al./2018 [2] 8 0 0 0 0 7 Conservative: 5/8 solved NA NA 40% (6/15)
Endoscopic: −/−
Percutaneous: −/−
Surgical: 4/7 solved
  1. amean, NA not available